Captrust Financial Advisors grew its stake in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 3.1% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 115,962 shares of the company's stock after buying an additional 3,473 shares during the period. Captrust Financial Advisors' holdings in Colgate-Palmolive were worth $10,542,000 as of its most recent SEC filing.
Several other institutional investors also recently made changes to their positions in CL. Kohmann Bosshard Financial Services LLC acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at about $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $27,000. Union Bancaire Privee UBP SA bought a new stake in shares of Colgate-Palmolive during the 4th quarter worth $32,000. Briaud Financial Planning Inc purchased a new position in Colgate-Palmolive during the 4th quarter valued at about $32,000. Finally, Wintrust Investments LLC acquired a new stake in Colgate-Palmolive during the fourth quarter valued at $33,000. 80.41% of the stock is owned by hedge funds and other institutional investors.
Colgate-Palmolive Stock Performance
NYSE CL traded down $1.98 during trading on Tuesday, reaching $87.16. 2,401,335 shares of the company's stock were exchanged, compared to its average volume of 5,384,424. Colgate-Palmolive has a fifty-two week low of $85.32 and a fifty-two week high of $109.30. The stock has a market capitalization of $70.64 billion, a P/E ratio of 24.76, a PEG ratio of 4.20 and a beta of 0.39. The business has a 50 day moving average price of $92.16 and a 200-day moving average price of $91.43. The company has a debt-to-equity ratio of 13.40, a current ratio of 0.92 and a quick ratio of 0.58.
Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, April 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.86 by $0.05. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. The company had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.92 billion. During the same quarter in the prior year, the business earned $0.86 earnings per share. The firm's revenue for the quarter was down 3.0% on a year-over-year basis. Sell-side analysts forecast that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.
Colgate-Palmolive announced that its board has authorized a stock buyback program on Thursday, March 20th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the company to buy up to 6.8% of its shares through open market purchases. Shares buyback programs are usually a sign that the company's leadership believes its stock is undervalued.
Colgate-Palmolive Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Thursday, April 17th will be given a dividend of $0.52 per share. The ex-dividend date is Thursday, April 17th. This represents a $2.08 dividend on an annualized basis and a yield of 2.39%. This is an increase from Colgate-Palmolive's previous quarterly dividend of $0.50. Colgate-Palmolive's dividend payout ratio is currently 58.76%.
Analysts Set New Price Targets
Several equities analysts recently issued reports on CL shares. StockNews.com lowered Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Raymond James restated an "outperform" rating and set a $105.00 price target (down from $110.00) on shares of Colgate-Palmolive in a research report on Monday, February 3rd. UBS Group increased their price objective on Colgate-Palmolive from $105.00 to $109.00 and gave the company a "buy" rating in a research report on Thursday, April 17th. JPMorgan Chase & Co. increased their price objective on Colgate-Palmolive from $95.00 to $103.00 and gave the company an "overweight" rating in a research report on Monday, April 28th. Finally, Wells Fargo & Company upped their price objective on Colgate-Palmolive from $83.00 to $88.00 and gave the company an "underweight" rating in a report on Wednesday, April 2nd. One analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $102.39.
Check Out Our Latest Stock Report on Colgate-Palmolive
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Further Reading
Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
